ABSTRACT

The last chapter is dedicated to present a campaign to experimentally validate in vivo the personalized model of the human knee, for enhancing the inter-individual reproducibility of a measurement method for monitoring Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) after transdermal delivery.